Highest Quality Biological Products, (No Diagnostic Substances) Stocks 2026

Top quality Biological Products, (No Diagnostic Substances) stocks in 2026 ranked by Quality of Company score. Multi-factor analysis across 32 fundamental signals.

131 stocks analyzed Updated 2026-05-29
# Ticker Company QOC Price QOC Score
1 EXEL Exelixis, Inc. 10.0 $50.48 10.0/10
2 GILD Gilead Sciences, Inc. 10.0 $134.43 10.0/10
3 HALO Halozyme Therapeutics, Inc. 10.0 $66.54 10.0/10
4 NBIX Neurocrine Biosciences, Inc. 10.0 $158.30 10.0/10
5 CGEN Compugen Ltd. 9.0 $2.63 9.0/10
6 BIIB Biogen Inc. 8.4 $196.00 8.4/10
7 IMCR Immunocore Holdings plc 8.2 $28.89 8.2/10
8 CSBR Champions Oncology, Inc. 8.1 $5.83 8.1/10
9 VCEL Vericel Corporation 7.8 $33.33 7.8/10
10 KRYS Krystal Biotech, Inc. 7.7 $309.03 7.7/10
11 P••• Protalix ••••• •.• $•••.•• ••.•%
12 R••• Repligen ••••• •.• $•••.•• ••.•%
13 T••• Bio-Techne ••••• •.• $•••.•• ••.•%
14 K••• Kymera ••••• •.• $•••.•• ••.•%
15 M••• Moderna, ••••• •.• $•••.•• ••.•%
16 F••• 4D ••••• •.• $•••.•• ••.•%
17 V••• Vir ••••• •.• $•••.•• ••.•%
18 D••• Denali ••••• •.• $•••.•• ••.•%
19 B••• BioCryst ••••• •.• $•••.•• ••.•%
20 B••• Black ••••• •.• $•••.•• ••.•%
🔒

Unlock the Full Highest Quality Biological Products, (No Diagnostic Substances) Stocks 2026 List

Screen all 131 Biological Products, (No Diagnostic Substances) stocks with 13 institutional-grade valuation models. Updated daily from SEC EDGAR filings.

Access Full Screening — From $27/mo →

How CirclFi Ranks Biological Products, (No Diagnostic Substances) Stocks

CirclFi analyzes 131 Biological Products, (No Diagnostic Substances) stocks daily using 13 independent institutional-grade valuation models. Each model processes SEC EDGAR 10-K and 10-Q financial filings (700+ XBRL tags), FRED macroeconomic data, and GDELT news sentiment.

The highest quality biological products, (no diagnostic substances) stocks 2026 ranking uses qoc score as the primary sort criterion. Models span intrinsic valuation (Bayesian DCF with 10,000 Monte Carlo simulations, EPV), scenario analysis (First Chicago), regime-switching (Markov DDM), and machine learning (ML-RIV, FTNN Topology).